Rege Nephro Co. Ltd. Revenue and Competitors

Kyoto, jp

Location

N/A

Total Funding

Biotech

Industry

Employee Data

  • Rege Nephro Co. Ltd. has 12 Employees.(i)
  • Rege Nephro Co. Ltd. grew their employee count by 71% last year.

Rege Nephro Co. Ltd.'s People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A1742%N/AN/A
#2
N/A90%N/AN/A
#3
N/A1271%N/AN/A
#4
N/A60%N/AN/A
#5
N/A28314%N/AN/A
Add Company

What Is Rege Nephro Co. Ltd.?

Rege Nephro is a clinical-stage biotech company developing cell therapy for chronic kidney disease (CKD) and small molecule for autosomal dominant polycystic kidney disease (ADPKD), and founded in 2019.\nThere are 13 million patients with CKD in Japan, of which 340,000 are severe CKD patients forced to undergo artificial dialysis. The healthcare cost of dialysis is $12 billion, 4% of the total healthcare cost of Japan.\nHowever, there is still no curative treatment for CKD. Rege Nephro tries to treat patients suffering from CKD with cell therapy using nephron progenitor cells differentiated from iPS cells.

keywords:N/A

N/A

Total Funding

12

Number of Employees

N/A

Revenue (est)

71%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.8M2827%N/A
#2
$640.7M1868N/AN/A